RenovoCath: Delivering therapy where it matters

Standard treatments for pancreatic cancer are often ineffective as they cannot be directly delivered to the tumor.

A potential new option for targeted treatment is on the horizon.

Introducing RenovoCath™

Pancreatic cancer is one of the deadliest types of cancer. Despite several treatment options, it is projected to become the second-leading cause of cancer-related death in the United States around 2020, in part due to challenges in diagnosing and treating the disease. Pancreatic cancer is often not detected until it is advanced and considered inoperable. Standard treatments are often ineffective because they cannot be delivered directly to the tumor and are unable to penetrate the tumor tissue.

RenovoRx has developed RenovoCath™, a dual-balloon infusion catheter that reaches pancreatic tumors using a proprietary approach to deliver chemotherapy directly to the tumor

Sint officia quae actiones

Ita redarguitur ipse a sese, convincunturque scripta eius probitate ipsius ac moribus. Multa sunt dicta ab antiquis de contemnendis ac despiciendis rebus humanis; Bonum incolumis acies: misera caecitas.

Reprehendi potest, tamen accipio, quod dant. Quo modo autem philosophus loquitur? Duo Reges: constructio interrete. Quamquam tu hanc copiosiorem etiam soles dicere. Etenim nec iustitia nec amicitia esse omnino poterunt, nisi ipsae per se expetuntur.

Menu